Hodgkin Disease

Hodgkin disease is a cancer of the lymphatic system that results from abnormal growth of cells in the lymphatic system. These cells can spread to other parts of the body. It can affect people of any age, but it is most common in people between the ages of 20 and 40 and over the age of 55.

Showing 1–12 of 16 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price
Brentuximab Vedotin 12143547	CD30	Antibody-drug conjugate (ADC)	Adcetris®	5 mg/mL	–	2 mg	-80°C	02/2025	888,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab 8006657	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	08/2024	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAN6970	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	08/2018	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAP6351	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	10/2018	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAQ3795	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	02/2018	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAU3964	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	05/2019	390,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAW0883	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	01/2019	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAW6409	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	09/2020	338,00 €	view product Max: 8 Min: 1 Step: 1
Nivolumab AAX0742	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	11/2020	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAY2764	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	02/2021	405,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 6302603D04	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	07/2018	794,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302601E01	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	12/2018	794,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302607002	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	03/2019	794,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302613A05	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	07/2019	794,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab U001450	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	yes	2 mg	-80°C	04/2022	841,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab U029851	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	11/2022	952,80 €	view product Max: 10 Min: 1 Step: 1

Not looking for Hodgkin Disease?

Search our therapeutic molecules product database

Browse all drug aliquots in stock

Need support? Please contact us

Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin

+49 (0) 30 959 99 8831 info@evidentic.com

Hodgkin Disease

Hodgkin disease is a cancer of the lymphatic system that results from abnormal growth of cells in the lymphatic system. These cells can spread to other parts of the body. It can affect people of any age, but it is most common in people between the ages of 20 and 40 and over the age of 55.

Not looking for Hodgkin Disease?

Search our therapeutic molecules product database

© All rights reserved

Evidentic – The reference drug company

we are recruiting